L3VLUP
ProSign in

BMRN in the 13F filings

Biomarin Pharmaceutical Inc · CUSIP 09061G101

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2023
the date the book describes
Filed
14 Nov 2023
latest of these filings; the earliest 13 Nov 2023
Managers listing it
18
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q2 2023 and Q3 2023; 16 listed it in both
Shares listed
32,418,571
combined, among listed positions
Reported value
$2.9bn
combined, at the quarter end

Managers listing BMRN in Q3 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

18 of 18 holders

ActionFiling
Dodge & Cox14,153,503$1.3bn0.84%Trimmed-136,80014 Nov 2023 (the filing on sec.gov)
Capital Research Global Investors6,017,970$532m0.15%Trimmed-738,06213 Nov 2023 (the filing on sec.gov)
Viking Global Investors LP4,215,456$373m1.51%Added+58,67114 Nov 2023 (the filing on sec.gov)
Janus Henderson Group Ltd3,424,539$303m0.20%Added+34,89314 Nov 2023 (the filing on sec.gov)
Balyasny Asset Management LLC910,396$81m0.16%Addedn.a.14 Nov 2023 (the filing on sec.gov)
Renaissance Technologies LLC581,771$51m0.09%Trimmed-150,86714 Nov 2023 (the filing on sec.gov)
Two Sigma Advisers LP573,514$51m0.13%Trimmed-176,60014 Nov 2023 (the filing on sec.gov)
D. E. Shaw & Co.524,139$46munder 0.1%Trimmed-385,67814 Nov 2023 (the filing on sec.gov)
Two Sigma Investments LP513,998$45m0.12%Added+84,81014 Nov 2023 (the filing on sec.gov)
Squarepoint Ops LLC456,188$40m0.10%Added+138,89714 Nov 2023 (the filing on sec.gov)
Marshall Wace LLP207,687$18munder 0.1%Trimmedn.a.14 Nov 2023 (the filing on sec.gov)
Moore Capital Management LP195,200$17m0.32%Added+35,20014 Nov 2023 (the filing on sec.gov)
ExodusPoint Capital Management LP170,017$15m0.14%Trimmed-59,62613 Nov 2023 (the filing on sec.gov)
Bridgewater Associates LP161,394$14m0.09%Added+11,41813 Nov 2023 (the filing on sec.gov)
Hudson Bay Capital Management LP130,910$12m0.09%Added+77,91014 Nov 2023 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC95,001$8.4m0.07%Added+36,57414 Nov 2023 (the filing on sec.gov)
Verition Fund Management LLC66,176$5.9m0.07%Trimmed-5,12214 Nov 2023 (the filing on sec.gov)
Winton Group Ltd20,712$1.8m0.15%Added+16,49413 Nov 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2023 to Q3 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
16 in Q3 2024 to 12 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
BMRN by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201314$2.3bnn.a.n.a.
Q3 201314$2.8bnn.a.n.a.
Q4 201311$2.5bnn.a.n.a.
Q1 20148$2.1bnn.a.n.a.
Q2 20149$1.9bnn.a.n.a.
Q3 20148$2.5bnn.a.n.a.
Q4 201412$3.3bnn.a.n.a.
Q1 201515$5.4bnn.a.n.a.
Q2 201514$6.3bnn.a.n.a.
Q3 201520$5.1bnn.a.n.a.
Q4 201514$4.8bnn.a.n.a.
Q1 201610$3.4bnn.a.n.a.
Q2 201611$2.7bnn.a.n.a.
Q3 201617$3.7bnn.a.n.a.
Q4 201613$3.0bnn.a.n.a.
Q1 201711$3.2bnn.a.n.a.
Q2 201714$3.2bnn.a.n.a.
Q3 201716$3.9bnn.a.n.a.
Q4 201716$3.8bnn.a.n.a.
Q1 201817$3.3bnn.a.n.a.
Q2 201814$3.6bnn.a.n.a.
Q3 201814$3.6bnn.a.n.a.
Q4 201813$3.0bnn.a.n.a.
Q1 201915$3.1bnn.a.n.a.
Q2 201919$3.0bnn.a.n.a.
Q3 201913$2.1bnn.a.n.a.
Q4 201915$3.0bnn.a.n.a.
Q1 202014$2.5bnn.a.n.a.
Q2 202011$3.6bnn.a.n.a.
Q3 202012$3.0bnn.a.n.a.
Q4 202012$3.7bnn.a.n.a.
Q1 202110$3.1bnn.a.n.a.
Q2 202111$3.4bnn.a.n.a.
Q3 202114$3.0bnn.a.n.a.
Q4 202114$3.4bnn.a.n.a.
Q1 202219$3.0bnn.a.n.a.
Q2 202221$2.9bnn.a.n.a.
Q3 202225$3.1bnn.a.n.a.
Q4 202226$4.0bnn.a.n.a.
Q1 202320$3.3bnn.a.n.a.
Q2 202318$2.9bnn.a.n.a.
Q3 202318$2.9bnn.a.n.a.
Q4 202322$4.1bn148
Q1 202419$3.6bn164
Q2 202416$3.3bn106
Q3 202416$3.0bn98
Q4 202414$3.0bn112
Q1 202516$3.3bn123
Q2 202516$2.5bn125
Q3 202516$2.3bn105
Q4 202521$2.4bn2419
Q1 202615$2.6bn1426
Q2 202612$2.2bn1322

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BMRN and LLY →BMRN and JNJ →BMRN and VRTX →Choose a stock to compare with BMRN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BMRN, latest filings →Back to the 13F Explorer →